Key facts
- Procter & Gamble is acquiring supplements maker Thorne.
- P&G CEO Shailesh Jejurikar confirmed the acquisition to CNBC.
- The acquisition price is considered favorable given Thorne's growth rates and industry benchmarks.
- Thorne was previously a target for Haleon.
- Thorne's valuation was reported to be up to $4 billion.
Procter & Gamble is set to announce the acquisition of supplements maker Thorne, according to an interview with P&G CEO Shailesh Jejurikar. Jejurikar told CNBC that the price is favorable for Thorne's growth rates and aligns with industry benchmarks.
